amiodarone and ncx1000

amiodarone has been researched along with ncx1000 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chabli, A; Colin, P; Elimadi, A; Haddad, PS; Ouazzani-Chahdi, A; Spénard, J	1

Other Studies

1 other study(ies) available for amiodarone and ncx1000

Article	Year
Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity. Canadian journal of physiology and pharmacology, 2007, Volume: 85, Issue:2 Topics: Amiodarone; Animals; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Liver; Hepatocytes; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Nitrates; Protective Agents; Superoxides; Ursodeoxycholic Acid	2007

Article

Year

Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity.

Canadian journal of physiology and pharmacology, 2007, Volume: 85, Issue:2

Topics: Amiodarone; Animals; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Liver; Hepatocytes; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Nitrates; Protective Agents; Superoxides; Ursodeoxycholic Acid

2007